Ethics and economics in nutritional support.

Alan L Buchman
{"title":"Ethics and economics in nutritional support.","authors":"Alan L Buchman","doi":"10.1159/000083303","DOIUrl":null,"url":null,"abstract":"Enteral and parenteral nutritional support was developed to provide sustenance to patients who ordinarily were unable to meet their nutritional needs either because of an inability to eat or an inability to digest and absorb food. Undernutrition has been associated with increased infection risk, poor wound healing, increased postoperative complications, prolonged hospital stay, respiratory, cardiac, and hepatic dysfunction, as well as increased mortality. A clinical decision must be made about the provision of both nutrition as well as hydration fluids for patients otherwise able to eat in the usual fashion. Patients who had intestinal failure from either short bowel syndrome (congenital or acquired) or severe dysmotility disorders were doomed in the absence of parenteral nutrition. Soon after the advent of total parenteral nutrition (TPN) in the late 1960s and early 1970s, it was thought that TPN was the cure-all for many ills and it became integral to the management of the chemotherapy patient, bone marrow transplant patient, preoperative patient, burn patient, and trauma patient, among other patient subsets. It was once hypothesized that, because patients who received TPN had a significantly decreased serum cholesterol concentration, TPN might be a reasonable therapy for atherosclerotic heart disease [1]. As this therapy came under increasingly more widespread use, evidencebased medicine with regard to TPN began to evolve. It was found TPN did not increase the effectiveness of chemotherapy, improve bone marrow engraftment, result in decreased postoperative infections in only mildly or non-malnourished patients, and did not improve outcome in trauma (other than head trauma) or burn patients, and in fact was associated with significant treatment-related complications in some patients [2]. The survival rate Lochs H, Thomas DR (eds): Home Care Enteral Feeding. Nestlé Nutrition Workshop Series Clinical & Performance Program, vol 10, pp 143–166, Nestec Ltd., Vevey/S. Karger AG, Basel, © 2005.","PeriodicalId":18989,"journal":{"name":"Nestle Nutrition workshop series. Clinical & performance programme","volume":"10 ","pages":"143-166"},"PeriodicalIF":0.0000,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000083303","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nestle Nutrition workshop series. Clinical & performance programme","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000083303","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

Enteral and parenteral nutritional support was developed to provide sustenance to patients who ordinarily were unable to meet their nutritional needs either because of an inability to eat or an inability to digest and absorb food. Undernutrition has been associated with increased infection risk, poor wound healing, increased postoperative complications, prolonged hospital stay, respiratory, cardiac, and hepatic dysfunction, as well as increased mortality. A clinical decision must be made about the provision of both nutrition as well as hydration fluids for patients otherwise able to eat in the usual fashion. Patients who had intestinal failure from either short bowel syndrome (congenital or acquired) or severe dysmotility disorders were doomed in the absence of parenteral nutrition. Soon after the advent of total parenteral nutrition (TPN) in the late 1960s and early 1970s, it was thought that TPN was the cure-all for many ills and it became integral to the management of the chemotherapy patient, bone marrow transplant patient, preoperative patient, burn patient, and trauma patient, among other patient subsets. It was once hypothesized that, because patients who received TPN had a significantly decreased serum cholesterol concentration, TPN might be a reasonable therapy for atherosclerotic heart disease [1]. As this therapy came under increasingly more widespread use, evidencebased medicine with regard to TPN began to evolve. It was found TPN did not increase the effectiveness of chemotherapy, improve bone marrow engraftment, result in decreased postoperative infections in only mildly or non-malnourished patients, and did not improve outcome in trauma (other than head trauma) or burn patients, and in fact was associated with significant treatment-related complications in some patients [2]. The survival rate Lochs H, Thomas DR (eds): Home Care Enteral Feeding. Nestlé Nutrition Workshop Series Clinical & Performance Program, vol 10, pp 143–166, Nestec Ltd., Vevey/S. Karger AG, Basel, © 2005.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
营养支持的伦理和经济学。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The magnitude of the problem of malnutrition in Europe. Malnutrition in North America: where have we been? Where are we going? The economics of malnutrition. The need for consistent criteria for identifying malnutrition. Enteral nutrition reimbursement - the rationale for the policy: the US perspective.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1